Neuropilin-1

• 

  Subject Areas on Research

  • Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cells. 
  • Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. 
  • Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. 
  • Metabolism and vascular fatty acid transport. 
  • MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer. 
  • Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors. 
  • Protein profile of exosomes from trabecular meshwork cells. 
  • Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. 
  • VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model. 
  • Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. 
  • Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. 
  • Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression.